ACB
ACB
NASDAQ · Pharmaceuticals

Aurora Cannabis Inc

$2.93
+0.01 (+0.34%)
Financial Highlights (FY 2026)
Revenue
473.33M
Net Income
-179,766,090
Gross Margin
6.4%
Profit Margin
-38.0%
Rev Growth
+22.4%
D/E Ratio
0.05
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 6.4% 6.4% 34.7% 34.7%
Operating Margin -19.5% -17.6% 22.2% 26.8%
Profit Margin -38.0% -36.1% 18.4% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 473.33M 386.80M 70.84M 65.30M
Gross Profit 30.29M 24.76M 24.60M 22.67M
Operating Income -92,440,401 -67,987,546 15.73M 17.49M
Net Income -179,766,090 -132,213,353 13.06M 12.20M
Gross Margin 6.4% 6.4% 34.7% 34.7%
Operating Margin -19.5% -17.6% 22.2% 26.8%
Profit Margin -38.0% -36.1% 18.4% 18.7%
Rev Growth +22.4% +22.4% +2.1% +23.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.72M 5.72M 23.51M 23.98M
Total Equity 122.81M 122.81M 146.45M 147.96M
D/E Ratio 0.05 0.05 0.16 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -86,822,609 -67,403,349 20.07M 20.48M
Free Cash Flow 11.95M 8.74M